VOICED : Cuba inicia en enero proceso de aval ante OMS para dos vacunas anticovid

Cuba is in the process of obtaining WHO approval for its COVID-19 vaccines, Avdala, Soberana 02, and Soberana Plus. The approval process is complex and costly. Cuba has a history of developing its own vaccines, with a significant portion of its immunization program relying on domestically produced vaccines. Despite potential skepticism, Cuba is working on ensuring the consistency of its vaccine production, having produced 37 million doses in 2021. For more information, visit ISGlobal.org.

What is the main goal of Cuba's current efforts regarding its COVID-19 vaccines?

• To distribute them globally

• To receive WHO approval

• To increase production

• To develop new vaccines

Which Cuban vaccine was the first to receive emergency use authorization?

• Soberana Plus

• Soberana 02

• None of the above

• Abdala

Why did Cuba start developing its own vaccines in the 1980s?

• Due to a lack of resources

• Because of the U.S. embargo

• To compete with other countries

• To improve public health

What is a key factor the WHO considers for vaccine approval?

• The country of origin

• The color of the vaccine

• The cost of production

• The number of doses produced

How many doses did Cuba produce in 2021?

• 37 million

• 50 million

• 20 million

• 10 million